2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies.

IF 2.2 3区医学 Medicina oral, patologia oral y cirugia bucal Pub Date : 2023-11-01 DOI:10.4317/medoral.25997

M Pérez-Fierro, L Castellanos-Cosano, J-A Hueto-Madrid, J López-Jiménez, R-J Núñez-Vázquez, G Machuca-Portillo

{"title":"2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies.","authors":"M Pérez-Fierro, L Castellanos-Cosano, J-A Hueto-Madrid, J López-Jiménez, R-J Núñez-Vázquez, G Machuca-Portillo","doi":"10.4317/medoral.25997","DOIUrl":null,"url":null,"abstract":"Background: Evaluating 2-years implant loss and marginal bone loss in patients with hereditary coagulopathies, comparing with a healthy control group.Material and methods: 37 implants in 13 patients (17 haemophilia A, 20 Von-Willebrand disease) versus 26 implants in 13 healthy patients. Data measured through Lagervall-Jansson index (after surgery, at prosthetic loading, at 2 years).Statistics: Chi-square, Haberman's, ANOVA, Mann-Whitney-U. Significance p<0.05.Results: Haemorrhagic accidents in 2 coagulopathies patients (non-statistical differences). Hereditary coagulopathies patients suffered more hepatitis (p<0.05), HIV (p<0.05) and less previous periodontitis (p<0.01). Non-statistical differences in marginal bone loss among groups. 2 implants were lost in the hereditary coagulopathies and none in the control group (non-statistical differences). Hereditary coagulopathies patients had longer (p<0.001), and narrower implants (p<0.05) placed. 43.2% external prosthetic connection in hereditary coagulopathies patients (p<0.001); change of prosthetic platform more frequent in control group (p<0.05). 2 implants lost: external connection (p<0.05). Survival rate 96.8% (hereditary coagulopathies 94.6%, control group 100%).Conclusions: Implant and marginal bone loss at 2 years is similar in patients with hereditary coagulopathies and control group. Precautions should be taken on the treatment for hereditary coagulopathies patients, through prior haematological protocol. Implant loss only occurred in in a patient with Von-Willebrand´s disease.","PeriodicalId":18351,"journal":{"name":"Medicina oral, patologia oral y cirugia bucal","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635626/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina oral, patologia oral y cirugia bucal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4317/medoral.25997","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Evaluating 2-years implant loss and marginal bone loss in patients with hereditary coagulopathies, comparing with a healthy control group.

Material and methods: 37 implants in 13 patients (17 haemophilia A, 20 Von-Willebrand disease) versus 26 implants in 13 healthy patients. Data measured through Lagervall-Jansson index (after surgery, at prosthetic loading, at 2 years).

Statistics: Chi-square, Haberman's, ANOVA, Mann-Whitney-U. Significance p<0.05.

Results: Haemorrhagic accidents in 2 coagulopathies patients (non-statistical differences). Hereditary coagulopathies patients suffered more hepatitis (p<0.05), HIV (p<0.05) and less previous periodontitis (p<0.01). Non-statistical differences in marginal bone loss among groups. 2 implants were lost in the hereditary coagulopathies and none in the control group (non-statistical differences). Hereditary coagulopathies patients had longer (p<0.001), and narrower implants (p<0.05) placed. 43.2% external prosthetic connection in hereditary coagulopathies patients (p<0.001); change of prosthetic platform more frequent in control group (p<0.05). 2 implants lost: external connection (p<0.05). Survival rate 96.8% (hereditary coagulopathies 94.6%, control group 100%).

Conclusions: Implant and marginal bone loss at 2 years is similar in patients with hereditary coagulopathies and control group. Precautions should be taken on the treatment for hereditary coagulopathies patients, through prior haematological protocol. Implant loss only occurred in in a patient with Von-Willebrand´s disease.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

遗传性凝血病患者植入物的生存率和边缘骨丢失的2年回顾性观察性病例对照研究。

背景：与健康对照组相比，评估遗传性凝血病患者2年的植入物损失和边缘骨损失。材料和方法：13名患者（17名血友病A患者，20名血管性血友病患者）植入37个植入物，13名健康患者植入26个植入物。通过Lagervall-Jansson指数测量的数据（手术后，假体负荷，2年时）。统计：卡方、Haberman's、ANOVA、Mann-Whiteney-U。显著性p结果：2例凝血障碍患者发生出血事故（无统计学差异）。遗传性凝血病患者的肝炎发病率更高（结论：遗传性凝血症患者和对照组在2年时植入物和边缘骨丢失相似。应通过先前的血液学方案对遗传性凝血疾病患者的治疗采取预防措施。植入物丢失仅发生在Von Willebrand病患者中。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Medicina oral, patologia oral y cirugia bucal Medicine-Surgery

CiteScore

4.50

自引率

0.00%

发文量

期刊介绍： 1. Oral Medicine and Pathology: Clinicopathological as well as medical or surgical management aspects of diseases affecting oral mucosa, salivary glands, maxillary bones, as well as orofacial neurological disorders, and systemic conditions with an impact on the oral cavity. 2. Oral Surgery: Surgical management aspects of diseases affecting oral mucosa, salivary glands, maxillary bones, teeth, implants, oral surgical procedures. Surgical management of diseases affecting head and neck areas. 3. Medically compromised patients in Dentistry: Articles discussing medical problems in Odontology will also be included, with a special focus on the clinico-odontological management of medically compromised patients, and considerations regarding high-risk or disabled patients. 4. Implantology 5. Periodontology